Author:
Viscardi Giuseppe,Russo Giuseppe Lo,Ferrara Roberto,Garassino Marina C.
Reference79 articles.
1. Mutational heterogeneity in cancer and the search for new cancer genes;Lawrence;Nature.,2013
2. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity.,2013
3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med.,2012
4. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial;Rizvi;Lancet Oncol.,2015
5. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N Engl J Med.,2015